Wednesday, November 4, 2026Daily EditionIndependent journalism
BeCrypto NewsIndependent digital asset reporting
Sign in Write
BTC $80,639 +4.94%ETH $2,428.53 +7.29%SOL $96.32 +5.20%XRP $1.31 +3.55%BNB $715.90 +3.73%DOGE $0.0770 +4.41%Prices: CoinGecko,
Back
Markets

Viridian Therapeutics Posts $24.7 Million in Lumvoa Net Product Revenue for Q3 2026

By John Kim for TokenPost

Image: TokenPost

Total revenue was $25.752 million, and GAAP net loss per share was $0.81 on both basic and diluted bases.

Read the full story on TokenPost

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.

Latest in Markets

All Markets stories